Georgia Mandolesi Selected Research

Georgia Mandolesi Research Topics

Disease

24	Multiple Sclerosis 05/2024 - 06/2013
23	Inflammation (Inflammations) 10/2023 - 07/2011
14	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2024 - 07/2011
6	Neuroinflammatory Diseases 05/2024 - 09/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 01/2016
4	Disease Progression 01/2022 - 02/2016
3	Gliosis 01/2018 - 06/2013
3	Dystonia musculorum deformans type 1 08/2012 - 06/2010
3	Dystonia (Limb Dystonia) 08/2012 - 06/2010
2	Fatigue 08/2022 - 01/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2019
2	Pathologic Processes 01/2017 - 01/2016
1	COVID-19 10/2023
1	Relapsing-Remitting Multiple Sclerosis 10/2023
1	Cognitive Dysfunction 03/2023
1	Alzheimer Disease (Alzheimer's Disease) 03/2023
1	Mood Disorders (Mood Disorder) 10/2022
1	Necrosis 11/2021
1	Obesity 01/2020
1	Anhedonia 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Atrophy 01/2011
1	Catalepsy 06/2010

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2022 - 09/2011
6	Glutamic Acid (Glutamate)FDA Link 01/2020 - 06/2013
4	Proteins (Proteins, Gene)FDA Link 03/2023 - 06/2010
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2016
2	InterleukinsIBA 08/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2019
2	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021 - 02/2015
2	CuprizoneIBA 01/2019 - 01/2019
2	Neuroprotective AgentsIBA 01/2018 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 10/2012
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 04/2014
2	Cholinergic Agents (Cholinergics)IBA 08/2012 - 01/2011
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2011 - 06/2010
1	Interleukin-9 (Interleukin 9)IBA 05/2024
1	EndocannabinoidsIBA 04/2024
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 04/2024
1	Messenger RNA (mRNA)IBA 10/2023
1	VaccinesIBA 10/2023
1	EnzymesIBA 03/2023
1	Amyloid (Amyloid Fibrils)IBA 03/2023
1	Extracellular Matrix ProteinsIBA 01/2023
1	OsteopontinIBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022
1	Interleukin-2 (IL2)IBA 10/2022
1	Interleukin-10 (Interleukin 10)IBA 08/2022
1	ParvalbuminsIBA 11/2021
1	LipidsIBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2018
1	Platelet-Derived Growth FactorIBA 04/2018
1	laquinimodIBA 01/2018
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2018
1	InterferonsIBA 12/2017
1	Chemokine CCL5IBA 10/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2016
1	siponimodIBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	Cladribine FDA LinkGeneric 11/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2013
1	Glatiramer Acetate (Copaxone)FDA Link 06/2013
1	gamma-Aminobutyric Acid (GABA)IBA 07/2011
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2011
1	Haloperidol (Haldol)FDA LinkGeneric 06/2010
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 06/2010

Therapy/Procedure

1	Immunomodulation 10/2022
1	Transcranial Magnetic Stimulation 01/2022
1	Therapeutics 11/2021
1	Lasers (Laser) 06/2013
1	Axotomy 06/2013